Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,385 | -650 | -4,260 | -3,276 | -2,380 |
| Depreciation Amortization | 6 | 4 | 4 | 2 | 1 |
| Accounts receivable | -242 | -709 | -27 | -15 | -296 |
| Other Working Capital | -63 | -481 | -44 | 23 | 103 |
| Other Operating Activity | 726 | 901 | 427 | 341 | 325 |
| Operating Cash Flow | $-1,958 | $-935 | $-3,900 | $-2,925 | $-2,246 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -42 | -32 | -22 | -7 | -3 |
| Investing Cash Flow | $-42 | $-32 | $-22 | $-7 | $-3 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,373 | 6,324 | 3,539 | 1,990 | 1,990 |
| Financing Cash Flow | $6,373 | $6,324 | $3,539 | $1,990 | $1,990 |
| Exchange Rate Effect | N/A | N/A | N/A | 64 | 53 |
| Beginning Cash Position | 1,353 | 1,353 | 1,736 | 1,736 | 1,736 |
| End Cash Position | 5,726 | 6,710 | 1,353 | 858 | 1,530 |
| Net Cash Flow | $4,373 | $5,357 | $-383 | $-879 | $-206 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,958 | -935 | -3,900 | -2,925 | -2,246 |
| Capital Expenditure | -42 | -32 | -22 | -7 | -3 |
| Free Cash Flow | -2,000 | -967 | -3,922 | -2,932 | -2,249 |